|
361
|
Briviact oral solution 10mg/mL, 300mL/瓶
|
|
|
362
|
BREZTRI AEROSPHERE
|
|
|
363
|
擴增含eftrenonacog alfa 成分藥品(如Alprolix)之給付範圍
|
|
|
364
|
Refixia powder and solvent for solution for injection
|
|
|
365
|
Romiplate 250μg injection
|
|
|
366
|
Verquvo 2.5mg、5mg 及10mg film-coated tablets
|
|
|
367
|
達伯坦錠 (Pemazyre Tablets)
|
|
|
368
|
舒肺樂凍晶注射劑 (Nucala Power for Solution for Injection)
|
|
|
369
|
偉卡沃膜衣錠 (Verquvo)
|
|
|
370
|
Otezla Film-coated Tablets 30mg
|
|
|
371
|
Trelegy Ellipta 92/55/22 mcg Inhalation Powder、Trelegy Ellipta 184/55/22 mcg Inhalation Powder
|
|
|
372
|
貝瑞酶凍晶注射劑 (Nexviazyme 10 mg/mL Powder for Concentrate for Solution for Infusion)
|
|
|
373
|
Cretrol
|
|
|
374
|
Otezla Film-coated Tablets 30mg
|
|
|
375
|
修訂Cholic acid (如Cholbam) 藥品給付規定
|
|
|
376
|
奔麗生凍晶注射劑 (Benlysta Powder for Solution for Infusion)
|
|
|
377
|
Tremfya Solution for Injection 100mg/mL
|
|
|
378
|
Betosiban concentrate for solution for infusion 7.5mg/ml
|
|
|
379
|
Tractocile
|
|
|
380
|
Cosentyx 150mg/mL solution for injection、150mg powder for solution for injection
|
|
